16537-34-1Relevant articles and documents
Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase
Chen, Fener,De Clercq, Erik,Pannecouque, Christophe,Sang, Yali,Zhuang, Chunlin
supporting information, (2020/02/03)
Twenty-seven derivatives (40–66) were generated by pharmacophore fusing of sulfonylacetanilide-diarylpyrimidine (1) with rilpivirine or biphenyl-diarylpyrimidines. They displayed up to single-digit nanomolar activity against wild-type (WT) virus and vario